Printer Friendly

Aptar Pharma launches eDose Counter.

Aptar Pharma has launched the eDose Counter for metered dose inhalers (MDIs) designed to improve Asthma and C.O.P.D. patient adherence. The electronic dose counter aims to offer enhanced performance over currently marketed MDI dose indicators and counters using mechanical technology which does not always meet expectations for users, regulators and other stakeholders due to poor legibility of the numbers.

Electronic components can offer large, clear counter digits required for a wide range of users and medical conditions, and also allows for the incorporation of visual MDI priming reminders and feedback on use as well as end-of-product-life warnings.

[ILLUSTRATION OMITTED]

The eDose Counter for MDIs is designed to be easy-to-use and reliable, and contributes to patient compliance. It incorporates sensing technology for detection of the spray, which eliminates risks of miscounting. The sensing technology is versatile and compatible with any metering valve design, according to the company. The eDose Counter for MDIs includes inhaler priming and medication reminders-to-use and end-of-product-life warnings (flashing digits).

"Aptar Pharma is very pleased to launch our novel electronic Dose Counter for MDIs. We believe the combination of Aptar Pharma's expertise in MDI valves and dose counters with our experience in electronically-assisted drug delivery devices creates a compelling offer to meet the needs of Asthma & CODP patients," said Jean-Marc Pardonge, president of Aptar Pharma Prescription Division.

More info: pharma.aptar.com

COPYRIGHT 2016 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:READER SHOWCASE
Publication:Contract Pharma
Date:Jun 1, 2016
Words:227
Previous Article:Johnson & Johnson.
Next Article:Pall launches Allegro STR 1000 bioreactor.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters